home Latest News Gerber Kawasaki Wealth & Investment Management Reduces Stake in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) – PressOracle

Gerber Kawasaki Wealth & Investment Management Reduces Stake in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) – PressOracle

This post was originally published on this site

Gerber Kawasaki Wealth & Investment Management lessened its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) by 1.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,441 shares of the company’s stock after selling 250 shares during the quarter. Gerber Kawasaki Wealth & Investment Management owned 0.27% of Invesco Dynamic Biotechnology & Genome ETF worth $679,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Investment House LLC acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF in the 4th quarter worth approximately $233,000. United Income Inc. acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF in the 4th quarter worth approximately $725,000. Janney Montgomery Scott LLC grew its position in shares of Invesco Dynamic Biotechnology & Genome ETF by 3.4% in the 4th quarter. Janney Montgomery Scott LLC now owns 9,087 shares of the company’s stock worth $428,000 after acquiring an additional 300 shares in the last quarter. PFG Advisors acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF in the 4th quarter worth approximately $1,411,000. Finally, YHB Investment Advisors Inc. grew its position in shares of Invesco Dynamic Biotechnology & Genome ETF by 19.0% in the 4th quarter. YHB Investment Advisors Inc. now owns 25,395 shares of the company’s stock worth $1,195,000 after acquiring an additional 4,050 shares in the last quarter.

NYSEARCA:PBE traded up $0.52 during midday trading on Friday, reaching $55.69. 8,326 shares of the company traded hands, compared to its average volume of 23,106. Invesco Dynamic Biotechnology & Genome ETF has a twelve month low of $43.17 and a twelve month high of $60.49.

ILLEGAL ACTIVITY NOTICE: “Gerber Kawasaki Wealth & Investment Management Reduces Stake in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)” was first published by PressOracle and is owned by of PressOracle. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://pressoracle.com/news/2019/03/16/gerber-kawasaki-wealth-investment-management-reduces-stake-in-invesco-dynamic-biotechnology-genome-etf-nysearcapbe.html.

Invesco Dynamic Biotechnology & Genome ETF Company Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Read More: SEC Filing

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com’s FREE daily email newsletter.